AuraGxP Trusted
Team of Leaders

AuraGxP exists because Vikas Agarwal, PhD, spent 25+ years on the buying side of the tools it replaces — and never found one built the way the work actually runs. Across CDO and operating roles, he stood up QMS programs, governed the CRO and CDMO relationships that quality depends on, and owned the vendor and spend management controls wrapped around them. He saw the same structural gap every time: quality, vendor, and spend management run as separate systems that don't talk, so compliant operations become a tax on time and capital instead of a source of leverage.

‍
AuraGxP is the platform he couldn't buy. Quality, vendor, and spend management — integrated and engineered for the operational realities of modern life sciences biotechs and built to make compliant operations a competitive advantage rather than a cost of doing business.

‍

Diana I. Shea is a Quality Leader and consultant with over 20 years of experience in the pharmaceutical and biotechnology industries. She specializes in building and scaling phase-appropriate Quality Management Systems, GxP Quality programs, and inspection readiness initiatives for emerging and growth-stage organizations.

‍

Diana has led Quality Operations functions including Document Control, Training, and Quality Systems, while implementing compliant digital platforms that improve operational efficiency, inspection preparedness, and quality culture. Her expertise includes developing sustainable quality frameworks that support innovation while maintaining regulatory Quality across GxP environments.

‍

She holds a Master of Science in Management, complementing her strategic leadership and operational expertise. Diana is driven by a strong commitment to patient safety, continuous improvement, and advancing innovative therapies through practical, effective, and scalable quality practices.

Jaidyn Nguyen brings 17 years of experience getting drugs to market, with leadership roles at Genentech, AbbVie, and Allergan spanning clinical development strategy, operations, and procurement. She's built and run trials from protocol through submission, managed complex vendor ecosystems, and knows where the inefficiencies live.

‍

At AuraGxP, she applies that intricate framework knowledge and operational depth to help biopharma companies make smarter, faster decisions about how clinical work gets done.

Hem Vora is a seasoned corporate finance professional with nearly two decades of experience across biotech, life sciences, clinical research, telecommunications, and consulting. As the founder of Dharma Consulting Corp, he specializes in FP&A, commercial finance, ERP implementation, financial modeling, and strategic analytics. Hem has held leadership roles at companies including Alkermes, Cytel, and Parexel, where he managed multimillion-dollar revenues, forecasting, revenue recognition, and operational finance. His expertise lies in driving financial efficiency, business growth, and cross-functional strategic partnerships.

With over two decades of leadership across global CROs, pharmaceutical companies, and entrepreneurial ventures, Suraj brings deep expertise in clinical operations, regulatory Quality, and digital transformation. A pharmacy graduate with a master’s in pharmacy practice, he has led high-stakes global studies, secured USFDA and EMA-backed marketing approvals, and co-founded a fast-growing clinical research organization built on scalable systems and cross-functional governance.

‍

At AuraGxP, Suraj leads commercial strategy, global partnerships, and go-to-market execution, while driving initiatives focused on operational excellence, capacity building, and industry-academia collaboration. His experience across global CRO leadership, regulatory strategy, and clinical operations helps shape AuraGxP into a platform designed for scalable, compliant, and digitally connected life sciences operations.

Krystal Kermott is the Head of Sales and Development at AuraGxP, bringing more than two decades of experience across clinical technology, pharmaceutical sales, and regulatory solutions. She has held leadership roles at Endpoint Clinical, Revvity Signals, Veeva Systems, IQVIA-owned Cenduit, Verisk 3E, and Boehringer Ingelheim. At Endpoint Clinical, she led the US West and Strategic Partner sales teams, achieving a 12x increase in new customer acquisition and 35% bookings growth. Krystal specializes in clinical trial technology, strategic partnerships, and business growth, with deep expertise in RTSM, CDMS, regulatory Quality, and digital transformation for life sciences organizations.
‍

She holds a B.S. in Biological Sciences from UC Santa Barbara and has completed graduate coursework in dispute resolution at Pepperdine Law and regulatory science at San Diego State University.

His career spans over 4 decades in the field of software engineering and commercial software development starting at British Aerospace Dynamics Group in the UK. With the emergence of personal computing, he transitioned into the realm of commercial software development. During this time, he spearheaded the creation of innovative software solutions tailored for diverse industries, including retail, automotive, and pharmaceuticals. Over three decades ago, he found his niche in the life sciences sector, a specialization he has passionately pursued ever since.

‍

He has a BSc in Physics and Engineering Science and MSc in Information Technology.